Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-09-25Clinical Trial Update: A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 bioequivalence study comparing the proposed talazoparib capsule formulation to the current formulation, plus a food-effect assessmen…
-
CLINICAL_TRIALS trial_result · 2024-09-20Clinical Trial Update: A Study to Characterize the Outcomes of Olaparib Maintenance Monotherapy in Newly Diagnosed BRCAwt Ovarian Cancer
Completed trial assessing outcomes of olaparib maintenance monotherapy in newly diagnosed BRCA wild-type ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2024-09-20Clinical Trial Update: Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma) [Phase 2]
Phase 2 Imperial College London study evaluating dual mTORC1/2 inhibition in advanced or recurrent epithelial ovarian, fallopian tube, or pr…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: BR55 in Characterization of Ovarian Lesions [Phase 2]
Phase 2 trial evaluating the BR55 ultrasound contrast agent for characterizing ovarian lesions in ovarian cancer was terminated, with result…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Phase I Study of Cantrixil in Patients With Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer. [Phase 1]
Phase I study of Cantrixil in ovarian, fallopian tube, and primary peritoneal cancers has completed. Results have been posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Clinical Trial of Combined Fostamatinib and Paclitaxel in Ovarian Cancer [Phase 1]
This Phase 1 trial evaluated the combination of fostamatinib and paclitaxel in ovarian cancer; the study completed and results were posted o…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Safety, Pharmacokinetics and Anti-tumor Activity of RP12146, in Patients With Solid Tumors [Phase 1]
Phase 1 study shows safety, pharmacokinetics and preliminary anti-tumor activity of RP12146 in patients with solid tumors, including extensi…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Connecting Audio and Radio Sensing Systems to Improve Care at Home
Completed study evaluating an audio and radio sensing system to support at-home care for cancer patients. The trial enrolled participants wi…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Genetically Engineered Cells (NY-ESO-1 TCR Engineered T Cells and HSCs) After Melphalan Conditioning Regimen in Treating Patients With Recurrent or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1]
A Phase 1 trial evaluating NY-ESO-1 TCR-engineered T cells with hematopoietic stem cells after melphalan conditioning in recurrent or refrac…
-
CLINICAL_TRIALS trial_result · 2024-08-30Clinical Trial Update: Platinum-based Chemotherapy With Atezolizumab and Niraparib in Patients With Recurrent Ovarian Cancer [Phase 3]
A Phase 3 trial evaluating platinum-based chemotherapy with Atezolizumab and Niraparib in patients with recurrent ovarian cancer has complet…
-
CLINICAL_TRIALS trial_result · 2024-08-29Clinical Trial Update: Pembrolizumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
A Phase 2 trial evaluated pembrolizumab in combination with carboplatin and paclitaxel for Stage III–IV ovarian, primary peritoneal, or fall…
-
CLINICAL_TRIALS trial_result · 2024-08-23Clinical Trial Update: Optimal Timing of BR55 CEUS of the Ovaries [Phase 2]
Phase 2 study evaluating the optimal timing of BR55 ultrasound contrast agent (CEUS) for imaging the ovaries in ovarian cancer; the trial wa…
-
CLINICAL_TRIALS trial_result · 2024-08-23Clinical Trial Update: Pilot Study of Liposomal Bupivacaine Redosing in Patients Undergoing Major Gynecologic Procedures [Phase 3]
Phase 3 pilot trial evaluating redosing liposomal bupivacaine for pain control in major gynecologic procedures has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: Vaccine Therapy and Cyclophosphamide in Treating Patients With Stage II-III Breast or Stage II-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 1]
Phase 1 trial of a cancer vaccine therapy combined with cyclophosphamide for patients with Stage II-III breast cancer or Stage II-IV ovarian…
-
CLINICAL_TRIALS trial_result · 2024-08-20Clinical Trial Update: Delayed Initiation of Olaparib Maintenance Therapy in Platinum Sensitive Recurrent Ovarian Cancer [Phase 2]
A Phase 2 trial evaluating delayed initiation of olaparib maintenance in platinum-sensitive recurrent ovarian cancer was terminated, with re…
-
CLINICAL_TRIALS trial_result · 2024-08-20Clinical Trial Update: QUILT-3.026: AMG 655 in Combination With AMG 479 in Advanced, Refractory Solid Tumors [Phase 1, Phase 2]
This update reports the termination of a Phase 1/2 trial of AMG 655 in combination with AMG 479 for advanced, refractory solid tumors, with …
-
CLINICAL_TRIALS trial_result · 2024-08-14Clinical Trial Update: Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer [EARLY_Phase 1]
Early-phase trial evaluating pharmacogenomics-guided use of supportive care medications in patients with advanced cancers; the study has com…
-
CLINICAL_TRIALS trial_result · 2024-08-09Clinical Trial Update: Intraperitoneal Infusion of ex Vivo-cultured Allogeneic NK Cells in Recurrent Ovarian Carcinoma Patients [Phase 1]
Phase 1 trial update on intraperitoneal infusion of ex vivo-cultured allogeneic NK cells in patients with recurrent ovarian cancer, recurren…
-
CLINICAL_TRIALS trial_result · 2024-08-07Clinical Trial Update: A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) [Phase 1, Phase 2]
ELU001, studied in Phase 1/2 in FRα-overexpressing solid tumors, has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-08-06Clinical Trial Update: Study of ASP0739 Alone and With Pembrolizumab in Advanced Solid Tumors With NY-ESO-1 Expression Participants [Phase 1, Phase 2]
Phase 1/2 study evaluating ASP0739 alone and in combination with pembrolizumab in NY-ESO-1 expressing advanced solid tumors was terminated, …
-
CLINICAL_TRIALS trial_result · 2024-08-06Clinical Trial Update: QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing Cancer [Phase 1, Phase 2]
This clinical trial update reports the termination of the Phase 1/2 study QUILT-3.040 evaluating ETBX-011 vaccine in combination with ALT-80…
-
CLINICAL_TRIALS trial_result · 2024-08-01Clinical Trial Update: Evaluation of the Safety and Tolerability of Niraparib With Everolimus in Advanced Gynecologic Malignancies and Breast [Phase 1]
Phase 1 study evaluating safety and tolerability of combining Niraparib with Everolimus in advanced gynecologic malignancies and breast canc…
-
CLINICAL_TRIALS trial_result · 2024-07-31Clinical Trial Update: Dose Escalation and Efficacy Study of mRNA-2416 for Intratumoral Injection Alone and in Combination With Durvalumab for Participants With Advanced Malignancies [Phase 1, Phase 2]
This clinical trial update reports dose-escalation and preliminary efficacy findings for intratumoral mRNA-2416 as a standalone therapy and …
-
CLINICAL_TRIALS trial_result · 2024-07-31Clinical Trial Update: A Study of PF-06873600 in People With Cancer [Phase 1, Phase 2]
Pfizer's PF-06873600 in Phase 1/2 for several cancers was terminated, with results posted in July 2024.
-
CLINICAL_TRIALS trial_result · 2024-07-26Clinical Trial Update: Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers [Phase 1]
Phase 1 clinical trial evaluating nab-paclitaxel in combination with bevacizumab in patients with unresectable stage IV melanoma or gynecolo…